ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 747825 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 747825; 2) Community: the network communities that were significantly associated with the response to NSC 747825; 3) Molecule: the relationships between components within communities and NSC 747825; 4) MDR: the compounds that were significantly associated with the NSC 747825.

NSC Compound Enrichment Correlation
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.039607714093338 0.3568881
NSC 637993 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[2-(diethylamino) ethylamino]-8-methoxy-1-methyl-, dihydrochloride 0.039607714093338 -0.015610749
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.039607714093338 0.2895952
NSC 645317 Sanguilutine pseudobase 0.039607714093338 0.38833246
NSC 651315 Null 0.039607714093338 -0.04998129
NSC 657822 (1R)-3,3-Dibromocamphor 0.039607714093338 0.48074505
NSC 672131 Null 0.039607714093338 0.51451322
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.039607714093338 0.25352413
NSC 690116 Null 0.039607714093338 0.35840443
NSC 693563 Null 0.039607714093338 0.27076101
Total:63  Current:54    [First] [Prev] [Next] [Last]